EOSINOPHILIC GASTROENTERITIS
Clinical trials for EOSINOPHILIC GASTROENTERITIS explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC GASTROENTERITIS trials appear
Sign up with your email to follow new studies for EOSINOPHILIC GASTROENTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for rare gut disorder
Disease control CompletedThis Phase 3 study tested an investigational drug called CC-93538 for adults and adolescents in Japan with eosinophilic gastroenteritis, a rare inflammatory gut disease. The trial aimed to see if the drug could reduce gut inflammation and improve symptoms like stomach pain, heavi…
Matched conditions: EOSINOPHILIC GASTROENTERITIS
Phase: PHASE3 • Sponsor: Celgene • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New injection tested for rare stomach disease
Disease control CompletedThis study tested whether dupilumab, an injectable medication, could reduce harmful inflammation in the stomachs of people with eosinophilic gastritis. Forty-one participants aged 12-70 received either the drug or a placebo injection every two weeks for 12 weeks. The main goal wa…
Matched conditions: EOSINOPHILIC GASTROENTERITIS
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC
-
Anti-Nausea drug could make colonoscopy prep easier for kids
Symptom relief CompletedThis study tested whether adding the anti-nausea medication ondansetron (Zofran) to standard bowel prep helps children complete their colonoscopy preparation more comfortably and effectively. Researchers compared children using just laxatives to those using laxatives plus ondanse…
Matched conditions: EOSINOPHILIC GASTROENTERITIS
Phase: PHASE4 • Sponsor: State University of New York - Downstate Medical Center • Aim: Symptom relief
Last updated Apr 04, 2026 01:35 UTC